Core Viewpoint - The company reported a significant decline in revenue and an increase in losses for the fiscal year ending December 31, 2023, primarily due to reduced sales in medical and healthcare products as well as e-commerce [1] Financial Performance - The company achieved revenue of HKD 36.332 million, representing a year-on-year decrease of 32.91% [1] - The loss attributable to equity shareholders amounted to HKD 35.934 million, which is an increase of 306.03% compared to the previous year [1] - The basic loss per share was HKD 0.079 [1] Revenue Breakdown - The decline in revenue was mainly attributed to decreased sales in medical and healthcare products [1] - E-commerce revenue, particularly from the sale of household and personal care products, also saw a reduction [1]